Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Mira T Keddis"'
Publikováno v:
PLoS ONE, Vol 18, Iss 5, p e0285412 (2023)
PurposeDirect oral anticoagulants (DOACs) are increasingly used in renal transplant recipients (RTR), but relatively understudied in this population. We assess the safety of post-transplant anticoagulation with DOACs compared to warfarin.MethodsWe co
Externí odkaz:
https://doaj.org/article/0685485199b140d98c6273c0ecfe4a84
Autor:
Regan Seipp, Nan Zhang, Sumi Sukumaran Nair, Hasan Khamash, Amit Sharma, Scott Leischow, Raymond Heilman, Mira T Keddis
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0244492 (2021)
BackgroundThe objective is to assess cardiovascular (CV), malignancy, infectious, graft outcomes and tacrolimus levels for the Indigenous patients compared to Whites after kidney transplant (KTx).Methods165 Indigenous and 165 White patients matched f
Externí odkaz:
https://doaj.org/article/00152d1f8bb947ce9ebd2bc8f20118ba
Autor:
Mira T Keddis, Amit Sharma, Muneeb Ilyas, Nan Zhang, Hasan Khamash, Scott J Leischow, Raymond L Heilman
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0207819 (2018)
BACKGROUND:The goal is to determine the delays and reduced rates of kidney transplant (KTx) for the Indigenous Americans and variables predictive of these outcomes at a large single transplant center. METHODS:300 Indigenous Americans and 300 non-Hisp
Externí odkaz:
https://doaj.org/article/1b4d2c0a21db4d87a4a1402fc918a5b1
Autor:
Mira T Keddis, Ziad El-Zoghby, Bruce Kaplan, Jeffrey W Meeusen, Leslie J Donato, Fernando G Cosio, D Eric Steidley
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0181123 (2017)
Solubility of Tumorigenicity 2 (sST2) is a novel biomarker that better stratifies risk of cardiovascular events (CVE) compared to cardiac troponin T(cTnT) in heart failure. We assessed the association of sST2 with the composite outcome of CVE and/or
Externí odkaz:
https://doaj.org/article/fef22865659d4e74880b1e2b7c2d059b
Autor:
Charat Thongprayoon, Janina Paula T. Sy-Go, Voravech Nissaisorakarn, Carissa Y. Dumancas, Mira T. Keddis, Andrea G. Kattah, Pattharawin Pattharanitima, Saraschandra Vallabhajosyula, Michael A. Mao, Fawad Qureshi, Vesna D. Garovic, John J. Dillon, Stephen B. Erickson, Wisit Cheungpasitporn
Publikováno v:
Diagnostics, Vol 11, Iss 11, p 2119 (2021)
Background: The objectives of this study were to classify patients with serum magnesium derangement on hospital admission into clusters using unsupervised machine learning approach and to evaluate the mortality risks among these distinct clusters. Me
Externí odkaz:
https://doaj.org/article/3ab80296b4334b97afb4bc0d2561f609
Autor:
Jonathan P. Moore, David J. Mauler, Gopal L. Narang, Karen L. Stern, Mitchell R. Humphreys, Mira T. Keddis
Publikováno v:
International Urology and Nephrology. 54:2819-2825
Autor:
Reza Roshandel, Christine W. Liaw, Mira T. Keddis, John C. Lieskec, Kevin Koo, Aaron M. Potretzke
Publikováno v:
Journal of Urology. 209
Autor:
Matthew J. Wiest, Chao Gu, Hyoungjun Ham, Laurent Gorvel, Mira T. Keddis, Leroy W. Griffing, HyeMee Joo, Jean-Pierre Gorvel, Daniel D. Billadeau, SangKon Oh
Publikováno v:
Frontiers in Immunology. 14
Plasmacytoid dendritic cells (pDCs) exhibit bifurcated cytokine responses to TLR9 agonists, an IRF7-mediated type 1 IFN response or a pro-inflammatory cytokine response via the activation of NF-κB. This bifurcated response has been hypothesized to r
Autor:
Filippo Pinto e Vairo, Jennifer L. Kemppainen, Carolyn R. Rohrer Vitek, Denise A. Whalen, Kayla J. Kolbert, Kaitlin J. Sikkink, Sarah A. Kroc, Teresa Kruisselbrink, Gabrielle F. Shupe, Alyssa K. Knudson, Elizabeth M. Burke, Elle C. Loftus, Lorelei A. Bandel, Carri A. Prochnow, Lindsay A. Mulvihill, Brittany Thomas, Dale M. Gamble, Courtney B. Graddy, Giovanna G. Moreno Garzon, Idara U. Ekpoh, Eva M. Carmona Porquera, Fernando C. Fervenza, Marie C. Hogan, Mireille El Ters, Kenneth J. Warrington, III John M. Davis, Matthew J. Koster, Amir B. Orandi, Matthew L. Basiaga, Adrian Vella, Seema Kumar, Ana L. Creo, Aida N. Lteif, Siobhan T. Pittock, Peter J. Tebben, Ejigayehu G. Abate, Avni Y. Joshi, Elizabeth H. Ristagno, Mrinal S. Patnaik, Lisa A. Schimmenti, Radhika Dhamija, Sonia M. Sabrowsky, Klaas J. Wierenga, Mira T. Keddis, Niloy Jewel J. Samadder, Richard J. Presutti, Steven I. Robinson, Michael C. Stephens, Lewis R. Roberts, William A. Faubion, Sherilyn W. Driscoll, Lily C. Wong-Kisiel, Duygu Selcen, Eoin P. Flanagan, Vijay K. Ramanan, Lauren M. Jackson, Michelle L. Mauermann, Victor E. Ortega, Sarah A. Anderson, Stacy L. Aoudia, Eric W. Klee, Tammy M. McAllister, Konstantinos N. Lazaridis
Background In the United States, rare disease (RD) is defined as a condition that affects fewer than 200,000 individuals. Collectively, RD affects an estimated 30 million Americans. A significant portion of RD has an underlying genetic cause; however
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::839c4d8f56cc2433ebcbe0bfafd53f7a
https://doi.org/10.21203/rs.3.rs-2617916/v1
https://doi.org/10.21203/rs.3.rs-2617916/v1
Autor:
Daniel Khan, Nan Zhang, Bassam G. Abu Jawdeh, Sundararaman Swaminathan, Sumi Nair, Mira T. Keddis
Publikováno v:
American Journal of Nephrology.
Introduction: This study describes patient characteristics and examines graft function of kidney transplant recipients (without primary hyperoxaluria) with elevated plasma oxalate (POx) and enteric risk factors prior to transplant at our institution.